Skip to main content

Table 6 Factors associated with NADC-IR

From: Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors

 

Controls

Cases

OR

95%

CI

p-value

p-overall

OR

95%

CI

p-value

p-overall

Age per 5 years

  

1.43

1.05

1.94

0.023

      

HCV core antibody

            

Negative

32

16

          

Positive

2

4

1.64

0.30

8.94

0.566

0.206

     

Missing

13

6

0.82

0.23

2.89

0.756

      

HBV surface antigen

            

Negative

24

14

3.26

0.55

19.25

0.192

0.454

     

Positive

3

3

1.03

0.25

4.21

0.972

      

Missing

20

9

          

CDC A

23

3

          

CDC B

7

10

9.29

1.74

49.63

0.009

0.032

32.72

2.22

481.07

0.011

0.041

CDC C

16

11

5.96

1.11

32.13

0.038

 

12.14

0.84

175.11

0.067

 

Missing

1

2

13.50

0.81

223.93

0.069

 

22.30

0.54

913.42

0.101

 

CD4 cells/mm 3

            

<= 100

2

6

          

101-200

5

5

0.26

0.02

2.85

0.271

0.021

0.79

0.04

14.43

0.876

0.041

201-350

10

6

0.05

0.00

0.94

0.045

 

0.03

0.00

2.15

0.108

 

>= 351

19

5

0.03

0.00

0.44

0.011

 

0.01

0.00

0.48

0.022

 

Missing

11

4

0.05

0.00

0.89

0.041

 

0.04

0.00

1.38

0.075

 

ART

            

Never

9

5

0.65

0.13

3.16

0.595

      

Ever

38

19

--

--

--

--

      

Missing

0

2

          

Smoking

            

Never

22

6

          

Ever

8

14

6.06

1.52

24.21

0.011

0.020

     

Missing

17

6

0.95

0.20

4.66

0.953

      
  1. ART: antiretroviral treatment
Back to article page

Journal of the International AIDS Society

ISSN: 1758-2652